Who we are $33.3bn Sales unchanged at $33,269 million ($32,804 million in 2009) $13.6bn Core operating profit unchanged at $13,603 million ($13,621 million in 2009) $6.71 Core EPS for the full year increased by 5% to $6.71 ($6.32 in 2009) $2.1bn Net share repurchases totalled $2,110 million ($nil in 2009)
About creating your own report

Create your own customised report PDF with only the information you need. You can add this page or remove it once selected. You can also go to the downloads page, view and edit your selections and then download your personalised report PDF.

6 Focus on six areas of healthcare 61,000 61,000 employees worldwide 10 10 medicines with sales of over $1 billion in 2010 100 Active in over 100 countries

AstraZeneca is a focused, integrated, innovation-driven, global, prescription-based biopharmaceutical business

Our mission is to make a meaningful difference to patient health through great medicines

We are committed to acting responsibly and to the sustainable development of our business

Our mission requires us to do things in the right way – to behave in accordance with our values and to act with integrity

We believe that our approach delivers lasting value for patients, society and our shareholders